• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

This product is currently not available for purchase.


COPD Market Forecast Product Image

COPD Market Forecast

  • ID: 2014027
  • November 2011
  • 6 pages
  • Datamonitor

New product launches for COPD across the seven major markets will override generic erosion and boost market value from $8.2bn in 2011 to $9.6bn by 2020, representing a positive 2011–20 CAGR of 1.8%. Datamonitor forecasts 14 new product launches in COPD over the next 10 years, altering class dynamics and fracturing a market currently dominated by a handful of therapies.

Features and benefits

- Access Datamonitor’s patient based COPD market forecast for the seven major markets, with transparent methodology and clear assumptions.
- See how each new product launch will impact the market, and where the strongest competition lies.
- Gain insight into COPD market dynamics, and see where untapped market potential remains.
- Understand how currently marketed products are vulnerable to competition in the COPD market, and which products are insulated against brand erosion.


- Datamonitor forecasts that sales for COPD will reach $8.2bn in 2011 in the seven major markets, growing to $9.6bn by 2020, representing a positive 2011–20 CAGR of 1.8%, large untapped potential remains. Datamonitor’s survey of 125 pulmonologists shows READ MORE >

Features and benefits
Key questions answered in this report
Forecasting methodology

Note: Product cover images may vary from those shown

Our Clients

Our clients' logos